Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
oral contraceptive
|
| gptkbp:activeIngredient |
gptkb:ethinyl_estradiol
norethindrone |
| gptkbp:alternativeName |
Norinyl 1+35
Norinyl 1+50 |
| gptkbp:ATCCode |
gptkb:G03AA05
|
| gptkbp:contraindication |
gptkb:liver_disease
history of thromboembolic disorders known or suspected pregnancy undiagnosed vaginal bleeding |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:hasPackSize |
21 tablets
|
| https://www.w3.org/2000/01/rdf-schema#label |
Norinyl-21
|
| gptkbp:marketedAs |
gptkb:Pfizer
|
| gptkbp:mechanismOfAction |
alters cervical mucus
changes endometrial lining inhibits ovulation |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regimen |
21 days active tablets, 7 days off
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache breast tenderness weight change |
| gptkbp:usedFor |
birth control
|
| gptkbp:bfsParent |
gptkb:mestranol
|
| gptkbp:bfsLayer |
8
|